Brief: Alligator Bioscience Announces Optimize-1 Trial Update; Cohort Fully Dosed With No Adverse Effects Reported
Jan 18 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR BIOSCIENCE ANNOUNCES OPTIMIZE-1 TRIAL UPDATE:
COHORT
FULLY DOSED WITH NO ADVERSE EFFECTS REPORTED
Source text for Eikon: ID:nPn4dyljxa
Further company coverage: ATORX.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln